Tumor necrosis factor-alpha polymorphism at position -238 in Preeclampsia

Iranian Red Crescent Medical Journal

Volumn 16, Issue 1, 2014, Pages

  Naderi, Mohammad ^a   Yaghootkar, Hanieh ^b   Tara, Fatemeh ^a   Tavakkol Afshari, Jalil ^c   Farid Hosseini, Reza ^c   Ghayour Mobarhan, Majid ^d   Shapouri Moghadam, Abbas ^c   Mirteimouri, Masoumeh ^a   Tara, Seyedeh Maryam ^e  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF EXETER   (United Kingdom)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Geneticfunding; Polymorphism; Pre Eclampsia; Tumor necrosis factor alpha

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CASE CONTROL STUDY; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANCY; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

EID: 84895814319     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: 10.5812/ircmj.11195     Document Type: Article

References (26)

1. Pazarbasi A, Kasap M, Guzel AI, Kasap H, Onbasioglu M, Ozbakir B, et al. Polymorphisms in the tumor necrosis factor-alpha gene in Turkish women with pre-eclampsia and eclampsia. Acta Med Okayama. 2007;61(3):153-160.
2. Rusterholz C, Hahn S, Holzgreve W. Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia. Semin Immunopathol. 2007;29(2):151-162.
3. Mirahmadian M, Kalantar F, Heidari G, Safdarian L, Mansouri R, Amirzargar AA. Association of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in Iranian patients with pre-eclampsia. Am J Reprod Immunol. 2008;60(2):179-185.
4. Haider S, Knofer M. Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium. Placenta. 2009;30(2):111-123.
5. North RA, McCowan LM, Dekker GA, Poston L, Chan EH, Stewart AW, et al. Clinical risk prediction for pre-eclampsia in nullipa-rous women: development of model in international prospective cohort. BMJ. 2011;342:d1875.
6. Chesley LC, Cooper DW. Genetics of hypertension in pregnancy: possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women. Br J Obstet Gynaecol. 1986;93(9):898-908.
7. Daher S, Sass N, Oliveira LG, Mattar R. Cytokine genotyping in preeclampsia. Am J Reprod Immunol. 2006;55(2):130-135.
8. Valente FP, Tan CR, Temple SE, Phipps M, Witt CS, Kaur G, et al. The evolution and diversity of TNF block haplotypes in European, Asian and Australian Aboriginal populations. Genes Immun. 2009;10(7):607-615.
9. Acog Committee on Practice Bulletins--Obstetrics. ACOG practice bulletin. Diagnosis and management of preeclamp-sia and eclampsia. Number 33, January 2002. Obstet Gynecol. 2002;99(1):159-167.
10. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
11. Williams PJ, Broughton Pipkin F. The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):405-417.
12. Serrano NC. Immunology and genetic of preeclampsia. Clin Dev Immunol. 2006;13(2-4):197-201.
13. Xie C, Yao MZ, Liu JB, Xiong LK. A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia. Cytokine. 2011;56(3):550-559.
14. Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab. 2001;86(6):2505-2512.
15. Goksu Erol AY, Nazli M, Yildiz SE. Expression levels of cyclooxy-genase-2, tumor necrosis factor-alpha and inducible NO syn-thase in placental tissue of normal and preeclamptic pregnancies. J Matern Fetal Neonatal Med. 2012;25(6):826-830.
16. Marusic J, Prusac IK, Tomas SZ, Karara JR, Roje D. Expression of inflammatory cytokines in placentas from pregnancies complicated with preeclampsia and HELLP syndrome. J Matern Fetal Neonatal Med. 2013;26(7):680-685.
17. Wang Y, Walsh SW. TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol. 1996;32(2):157-169.
18. Wu ZM, Yang H, Li M, Yeh CC, Schatz F, Lockwood CJ, et al. Pro-inflammatory cytokine-stimulated first trimester decidual cells enhance macrophage-induced apoptosis of extravillous tropho-blasts. Placenta. 2012;33(3):188-194.
19. Crocker IP, Barratt S, Kaur M, Baker PN. The in-vitro characterization of induced apoptosis in placental cytotrophoblasts and syn-cytiotrophoblasts. Placenta. 2001;22(10):822-830.
20. Yui J, Garcia-Lloret M, Wegmann TG, Guilbert LJ. Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta. 1994;15(8):819-835.
21. Leisser C, Saleh L, Haider S, Husslein H, Sonderegger S, Knofer M. Tumour necrosis factor-alpha impairs chorionic gonadotrophin beta-subunit expression and cell fusion of human villous cyto-trophoblast. Mol Hum Reprod. 2006;12(10):601-619.
22. LaMarca BB, Bennett WA, Alexander BT, Cockrell K, Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. Hypertension. 2005;46(4):1022-1025.
23. Canto-Cetina T, Canizales-Quinteros S, de la Chesnaye E, Coral-Vazquez R, Mendez JP, Canto P. Analysis of C-850T and G-308A polymorphisms of the tumor necrosis factor-alpha gene in Maya-Mestizo women with preeclampsia. Hypertens Pregnancy. 2007;26(3):283-291.
24. Heiskanen J, Romppanen EL, Hiltunen M, Iivonen S, Mannermaa A, Punnonen K, et al. Polymorphism in the tumor necrosis factor-alpha gene in women with preeclampsia. J Assist Reprod Genet. 2002;19(5):220-223.
25. Vural P, Degirmencioglu S, Saral NY, Demirkan A, Akgul C, Yildir-im G, et al. Tumor necrosis factor alpha, interleukin-6 and inter-leukin-10 polymorphisms in preeclampsia. J Obstet Gynaecol Res. 2010;36(1):64-71.
26. Bombell S, McGuire W. Tumour necrosis factor (-308A) polymorphism in pre-eclampsia: meta-analysis of 16 case-control studies. Aust N Z J Obstet Gynaecol. 2008;48(6):547-551.